Photocytotoxic effect of pseudohypericin versus hypericin

被引:51
作者
Vandenbogaerde, AL
Kamuhabwa, A
Delaey, E
Himpens, BE
Merlevede, WJ
de Witte, PA
机构
[1] Katholieke Univ Leuven, Fac Farm, Lab Farmaceut Biol & Fytofarmacol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Fysiol, Gasthuisberg Onderwijs Navorsing, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Fac Geneeskunde, Afdeling Biochem, Gasthuisberg Onderwijs Navorsing, B-3000 Louvain, Belgium
关键词
cytotoxicity; hypericin; Hypericum; photosensitization; photodynamic therapy; pseudohypericin;
D O I
10.1016/S1011-1344(98)00163-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pseudohypericin and hypericin,the major photosensitizing constituents of Hypericum perforatum, are believed to cause hypericism; Since hypericin has been proposed as a photosensitizer for photodynamic cancer therapy, the photocytotoxicity of its congener pseudohypericin has been investigated. The presence of foetal calf serum (FCS) or albumin extensively inhibits the photocytotoxic effect of pseudohypericin against A431 tumour cells, and is associated with a large decrease in cellular uptake of the compound. These results suggest that pseudohypericin, in contrast to hypericin, interacts strongly with constituents of FCS, lowering its interaction with cells. Since pseudohypericin is two to three times more abundant in Hypericum than hypericin and the bioavailabilities of pseudohypericin and hypericin after oral administration are similar, these results suggest that hypericin, and not pseudohypericin, is likely to be the constituent responsible for hypericism. Moreover, the dramatic decrease of photosensitizing activity of pseudohypericin in the presence of serum may restrict its applicability in clinical situations. (C) 1998 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 48 条
[1]   A comparative analysis of the photosensitized inhibition of growth-factor regulated protein kinases by hypericin-derivatives [J].
Agostinis, P ;
DonellaDeana, A ;
Cuveele, J ;
Vandenbogaerde, A ;
Sarno, S ;
Merlevede, W ;
deWitte, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) :613-617
[2]   PHOTOSENSITIZED INHIBITION OF GROWTH FACTOR-REGULATED PROTEIN-KINASES BY HYPERICIN [J].
AGOSTINIS, P ;
VANDENBOGAERDE, A ;
DONELLADEANA, A ;
PINNA, LA ;
LEE, KT ;
GORIS, J ;
MERLEVEDE, W ;
VANDENHEEDE, JR ;
DEWITTE, P .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (11) :1615-1622
[3]   LASER PHOTOSENSITIZATION OF CELLS BY HYPERICIN [J].
ANDREONI, A ;
COLASANTI, A ;
COLASANTI, P ;
MASTROCINQUE, M ;
RICCIO, P ;
ROBERTI, G .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1994, 59 (05) :529-533
[4]  
BERGHOFER R, 1997, DTSCH APOTH Z, V47, P2569
[5]   Homo-association of hypericin in water and consequences on its photodynamic properties [J].
Burel, L ;
Jardon, P .
JOURNAL DE CHIMIE PHYSIQUE ET DE PHYSICO-CHIMIE BIOLOGIQUE, 1996, 93 (02) :300-316
[6]   PSEUDOHYPERICIN AND OTHER PHENANTHROPERYLENE QUINONES [J].
CAMERON, DW ;
RAVERTY, WD .
AUSTRALIAN JOURNAL OF CHEMISTRY, 1976, 29 (07) :1523-1533
[7]   HYPERICIN - A POTENTIAL ANTIGLIOMA THERAPY [J].
COULDWELL, WT ;
GOPALAKRISHNA, R ;
HINTON, DR ;
HE, SK ;
WEISS, MH ;
LAW, RE ;
APUZZO, MLJ .
NEUROSURGERY, 1994, 35 (04) :705-709
[8]   INHIBITION OF EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE-ACTIVITY BY HYPERICIN [J].
DEWITTE, P ;
AGOSTINIS, P ;
VANLINT, J ;
MERLEVEDE, W ;
VANDENHEEDE, JR .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (11) :1929-1936
[9]   PHOTOSENSITIZATION WITH ANTICANCER AGENTS .17. EPR STUDIES OF PHOTODYNAMIC-ACTION OF HYPERICIN - FORMATION OF SEMIQUINONE RADICAL AND ACTIVATED OXYGEN SPECIES ON ILLUMINATION [J].
DIWU, ZJ ;
LOWN, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 14 (02) :209-215
[10]   HYPERICIN AND ITS PHOTODYNAMIC-ACTION [J].
DURAN, N ;
SONG, PS .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1986, 43 (06) :677-680